Chronic GVHD is a major late complication of SCT. Chronic GVHD has received only a fraction of the research attention received by acute GVHD. Recent changes in SCT practice have made it imperative to ...

We report a patient who underwent allogeneic haematopoietic stem cell transplantation (HSCT) and donor lymphocyte infusion (DLI), and later developed acute hepatic failure followed by progressive ...

More than a year after the blood stem cell transplant for his aggressive leukemia, Ted Ave’Lallemant thought he was easing back into his regular life — more or less. He’d returned to his hometown of ...

In patients undergoing allogeneic hematopoietic stem-cell transplantation (HSCT), a calcineurin inhibitor plus methotrexate has been a standard prophylaxis against graft-versus-host disease (GVHD). A ...

A retrospective analysis of Canadian cases finds clinicians turn to a variety of therapies for chronic graft-vs-host disease (GVHD) if corticosteroids fail. A new review of chronic graft-vs-host ...

Allogeneic bone marrow transplant (BMT) is an essential treatment to cure patients with blood cancers such as leukemia. In patients who have undergone chemotherapy and radiation, a small number of ...

Graft-versus-host disease (GVHD) is a common side effect in people who receive cells from a donor (allogeneic transplant). It occurs when the transplanted cells recognize the recipient’s tissues as ...

Allogeneic bone marrow transplant (BMT) is an essential treatment to cure patients with blood cancers such as leukemia. In patients who have undergone chemotherapy and radiation, a small number of ...

Acute GvHD generally happens within the first 100 days after you have a stem cell transplant from another person. Sometimes it can be hard to tell if the symptoms are caused by GvHD or are other side ...

Overlap syndrome is when you have symptoms of both types. Another type is persistent, recurrent or late onset acute GvHD. Acute GvHD generally starts within 100 days of your transplant, but it can ...

Keep abreast with the latest news related to Graft versus Host Disease (GvHD) there are 83 news items on Graft versus Host Disease (GvHD) that covers updates, breakthroughs and in-depth reports. We ...

Allogeneic hematopoietic-cell transplantation is a mainstay of treatment for hematologic cancers, and the gut microbiota — the collection of archaea, bacteria, fungi, protists, and viruses that reside ...